Hodgkin's lymphoma is a type of lymphoma in which cancer originates from a specific type of white blood cells called lymphocytes. Symptoms may include fever, night sweats, and weight loss. Often there will be non-painful enlarged lymph nodes in the neck, under the arm, or in the groin. Those affected may feel tired or be itchy.
This report contains market size and forecasts of Hodgkin's Lymphoma Drugs in Global, including the following market information:
Global Hodgkin's Lymphoma Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hodgkin's Lymphoma Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Targeted Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hodgkin's Lymphoma Drugs include Pfizer, Roche, Merck, Bristol-Myers Squibb, Ono Pharmaceutical and Seattle Genetics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hodgkin's Lymphoma Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hodgkin's Lymphoma Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hodgkin's Lymphoma Drugs Market Segment Percentages, by Type, 2021 (%)
Targeted Therapy
Chemotherapy
Global Hodgkin's Lymphoma Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hodgkin's Lymphoma Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Hodgkin's Lymphoma Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hodgkin's Lymphoma Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hodgkin's Lymphoma Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hodgkin's Lymphoma Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Roche
Merck
Bristol-Myers Squibb
Ono Pharmaceutical
Seattle Genetics